- Home
- ABTS vs APTO Comparison
ABTS vs APTO Comparison
Compare ABTS & APTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABTS
- APTO
- Stock Information
- Founded
- ABTS 2010
- APTO 1986
- Country
- ABTS Hong Kong
- APTO Canada
- Employees
- ABTS N/A
- APTO N/A
- Industry
- ABTS Computer Software: Programming Data Processing
- APTO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ABTS Technology
- APTO Health Care
- Exchange
- ABTS Nasdaq
- APTO Nasdaq
- Market Cap
- ABTS 15.9M
- APTO 13.2M
- IPO Year
- ABTS N/A
- APTO N/A
- Fundamental
- Price
- ABTS $0.47
- APTO $0.18
- Analyst Decision
- ABTS
- APTO Strong Buy
- Analyst Count
- ABTS 0
- APTO 3
- Target Price
- ABTS N/A
- APTO $4.33
- AVG Volume (30 Days)
- ABTS 76.0K
- APTO 733.6K
- Earning Date
- ABTS 12-31-2024
- APTO 03-25-2025
- Dividend Yield
- ABTS N/A
- APTO N/A
- EPS Growth
- ABTS N/A
- APTO N/A
- EPS
- ABTS N/A
- APTO N/A
- Revenue
- ABTS $5,343,888.00
- APTO N/A
- Revenue This Year
- ABTS N/A
- APTO N/A
- Revenue Next Year
- ABTS N/A
- APTO N/A
- P/E Ratio
- ABTS N/A
- APTO N/A
- Revenue Growth
- ABTS 3970.67
- APTO N/A
- 52 Week Low
- ABTS $0.38
- APTO $0.13
- 52 Week High
- ABTS $1.07
- APTO $2.20
- Technical
- Relative Strength Index (RSI)
- ABTS 46.52
- APTO 36.06
- Support Level
- ABTS $0.44
- APTO $0.21
- Resistance Level
- ABTS $0.59
- APTO $0.23
- Average True Range (ATR)
- ABTS 0.04
- APTO 0.01
- MACD
- ABTS -0.00
- APTO -0.00
- Stochastic Oscillator
- ABTS 21.85
- APTO 10.33
About ABTS Abits Group Inc
Abits Group Inc is a digital data center operator with bitcoin self-mining operations.
About APTO Aptose Biosciences Inc.
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.